Phase 3 Randomized, Double Blind, Placebo Controlled Study Of The Efficacy And Safety Of 2 Doses Of CP-690,550 In Patients With Active Rheumatoid Arthritis On Background Methotrexate
Phase 3 Randomized, Double Blind, Placebo Controlled Study Of The Efficacy And Safety Of 2 Doses Of CP-690,550 In Patients With Active Rheumatoid Arthritis On Background Methotrexate
This study is designed to provide safety and efficacy data to support the development of CP-690,550 in patients with moderate to severe rheumatoid arthritis on background of methotrexate.
Inclusion Criteria:
Exclusion Criteria:
Bogota, Cundinamarca, Colombia
Praha 11 - Chodov, 148 00, Czechia
Hyderabad, Andhra Pradesh 500 004, India
Secunderabad, Andhra Pradesh 500003, India
Hitachi-shi, Ibaraki, Japan
Koushi, Kumamoto, Japan
Ohmura, Nagasaki, Japan
Ureshino-shi, Saga-ken, Japan
Kawagoe-shi, Saitama, Japan
Bunkyo-ku, Tokyo, Japan
Shinjuku-ku, Tokyo, Japan
Kweishan, Taoyuan County, 333, Taiwan